- Home
- ATXS vs AMPX Comparison
ATXS vs AMPX Comparison
Compare ATXS & AMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXS
- AMPX
- Stock Information
- Founded
- ATXS 2008
- AMPX 2008
- Country
- ATXS United States
- AMPX United States
- Employees
- ATXS N/A
- AMPX N/A
- Industry
- ATXS Biotechnology: Pharmaceutical Preparations
- AMPX Industrial Machinery/Components
- Sector
- ATXS Health Care
- AMPX Miscellaneous
- Exchange
- ATXS Nasdaq
- AMPX Nasdaq
- Market Cap
- ATXS 401.2M
- AMPX 331.4M
- IPO Year
- ATXS 2015
- AMPX N/A
- Fundamental
- Price
- ATXS $4.04
- AMPX $2.14
- Analyst Decision
- ATXS Strong Buy
- AMPX Strong Buy
- Analyst Count
- ATXS 5
- AMPX 8
- Target Price
- ATXS $26.60
- AMPX $8.75
- AVG Volume (30 Days)
- ATXS 369.7K
- AMPX 3.7M
- Earning Date
- ATXS 05-08-2025
- AMPX 05-08-2025
- Dividend Yield
- ATXS N/A
- AMPX N/A
- EPS Growth
- ATXS N/A
- AMPX N/A
- EPS
- ATXS N/A
- AMPX N/A
- Revenue
- ATXS N/A
- AMPX $24,167,000.00
- Revenue This Year
- ATXS N/A
- AMPX $167.05
- Revenue Next Year
- ATXS N/A
- AMPX $216.14
- P/E Ratio
- ATXS N/A
- AMPX N/A
- Revenue Growth
- ATXS N/A
- AMPX 166.95
- 52 Week Low
- ATXS $3.56
- AMPX $0.61
- 52 Week High
- ATXS $12.92
- AMPX $4.21
- Technical
- Relative Strength Index (RSI)
- ATXS 28.96
- AMPX 41.42
- Support Level
- ATXS $3.56
- AMPX $2.28
- Resistance Level
- ATXS $4.39
- AMPX $2.56
- Average True Range (ATR)
- ATXS 0.42
- AMPX 0.25
- MACD
- ATXS -0.04
- AMPX -0.04
- Stochastic Oscillator
- ATXS 22.61
- AMPX 5.88
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.
About AMPX Amprius Technologies Inc.
Amprius Technologies Inc is engaged in the production of silicon anodes for high-energy-density lithium-ion batteries. The company develops, manufactures and markets lithium-ion batteries for mobility applications, including the aviation, electric vehicle (EV) and light electric vehicle (LEV) industries. The company's batteries are used for existing and emerging aviation applications, including unmanned aerial systems, such as drones and high-altitude pseudo satellites.